621 related articles for article (PubMed ID: 19116753)
41. [Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].
Charvat JC; Brutsche M; Frey JG; Tschopp JM
Praxis (Bern 1994); 1998 Mar; 87(10):336-40. PubMed ID: 9545840
[TBL] [Abstract][Full Text] [Related]
42. Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions.
Ohm C; Park D; Vogen M; Bendick P; Welsh R; Pursel S; Chmielewski G
Am Surg; 2003 Mar; 69(3):198-202; discussion 202. PubMed ID: 12678474
[TBL] [Abstract][Full Text] [Related]
43. Pleurodesis in recurrent pleural effusions: a randomized comparison of a classical and a currently popular drug.
Ukale V; Agrenius V; Hillerdal G; Mohlkert D; Widström O
Lung Cancer; 2004 Mar; 43(3):323-8. PubMed ID: 15165091
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
Neto JD; de Oliveira SF; Vianna SP; Terra RM
Respirology; 2010 Jan; 15(1):115-8. PubMed ID: 19947987
[TBL] [Abstract][Full Text] [Related]
45. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting.
Saute M
Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586
[TBL] [Abstract][Full Text] [Related]
46. [Videothoracoscopic collagen pleurodesis in malignant pleural effusion].
Akopov AL; Varlamov VV; Egorov VI; Kondrat'ev VB; Pukhova ZI
Ter Arkh; 2004; 76(3):51-4. PubMed ID: 15108460
[TBL] [Abstract][Full Text] [Related]
47. Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.
Yildirim H; Metintas M; Ak G; Erginel S; Alatas F; Kurt E; Metintas S; Ucgun I
Lung; 2007 Dec; 185(6):349-54. PubMed ID: 17952507
[TBL] [Abstract][Full Text] [Related]
48. An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion.
Beck TN; Deneka AY; Chai L; Kanach C; Johal P; Alvarez NJ; Boumber Y; Golemis EA; Laub GW
BMC Cancer; 2019 Jun; 19(1):614. PubMed ID: 31234819
[TBL] [Abstract][Full Text] [Related]
49. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention.
Marrazzo A; Noto A; Casà L; Taormina P; Lo Gerfo D; David M; Mercadante S
J Pain Symptom Manage; 2005 Jul; 30(1):75-9. PubMed ID: 16043010
[TBL] [Abstract][Full Text] [Related]
50. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?
Terra RM; Junqueira JJM; Teixeira LR; Vargas FS; Pêgo-Fernandes PM; Jatene FB
Chest; 2009 Aug; 136(2):361-368. PubMed ID: 19349389
[TBL] [Abstract][Full Text] [Related]
51. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
[TBL] [Abstract][Full Text] [Related]
52. Management of malignant pleural effusion.
Chen H; Brahmer J
Curr Oncol Rep; 2008 Jul; 10(4):287-93. PubMed ID: 18778553
[TBL] [Abstract][Full Text] [Related]
53. Video-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital's experience.
Trotter D; Aly A; Siu L; Knight S
Heart Lung Circ; 2005 Jun; 14(2):93-7. PubMed ID: 16352262
[TBL] [Abstract][Full Text] [Related]
54. [Comparative study of video-assisted thoracoscopic surgery vs thoracic tube drainage in synthetic therapy for malignant pleural effusion secondary to non-small cell lung cancer].
Gu LJ; Wang WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1023-6. PubMed ID: 16864104
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
56. Survival Difference in Patients with Malignant Pleural Effusions Treated with Pleural Catheter or Talc Pleurodesis.
Liou DZ; Serna-Gallegos D; Chan JL; Borgella J; Akhmerov S; Soukiasian HJ
Am Surg; 2016 Oct; 82(10):995-999. PubMed ID: 27779992
[TBL] [Abstract][Full Text] [Related]
57. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
58. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial.
Haddad FJ; Younes RN; Gross JL; Deheinzelin D
World J Surg; 2004 Aug; 28(8):749-53; discussion 753-4. PubMed ID: 15457352
[TBL] [Abstract][Full Text] [Related]
59. [Surgical therapy for malignant pleural effusions].
Ludwig C; Stoelben E
Zentralbl Chir; 2008 Jun; 133(3):218-21. PubMed ID: 18563684
[TBL] [Abstract][Full Text] [Related]
60. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
